Tom Edman
Analyst · Needham & Company
Thank you, Sameer. Good afternoon, and thank you for joining us for our third quarter 2020 conference call. These continue to be challenging times. And I hope that, all of you and your loved ones are safe and healthy. I'll begin with a review of our business strategy then an update on how COVID-19 has impacted our business followed by highlights from the quarter and a discussion of our third quarter results. Todd Schull, our CFO will follow with an overview of our Q3 2020 financial performance and our Q4 2020 guidance. We will then open the call to your questions. I am pleased to report that in the third quarter of 2020, TTM generated revenues and non-GAAP EPS above the guided range. Our diversified end markets allowed us to grow PCB revenues year-on-year despite weakness in the commercial aerospace and automotive end markets. In addition, we continued strong operational execution, overcame production inefficiencies, and extra cost due to COVID-19. The COVID-19 pandemic has created operational difficulties, macroeconomic uncertainty, and employee concerns. I am extremely proud of how TTM employees have worked to deliver excellent performance, despite the formidable and unprecedented challenges of this environment. Finally, I'd like to highlight that in Q3 we received the remaining proceeds of the mobility business unit divestiture and have applied them to repay our term loan B. Combined with strong cash flow from operations, our net debt-to-EBITDA ratio has dropped to 1.6 at the end of Q3. Next, I would like to provide an update on our long-term strategy. TTM is on a journey to transform our business to be less cyclical, more differentiated and more disciplined. We believe over time investors will be rewarded with more stable growth, strong cash flow performance, and improving margins. A key part of that strategy will be to add capabilities and products that are complementary to our current offerings internally and through acquisitions. The Anaren acquisition in 2018 represented a key step in this direction. Anaren provided us with engineering capabilities and a new market adjacency of RF subassemblies and components that enabled us to provide more value to our customers. We effectively paid for that transaction with the sale of the mobility business unit in 2020, which reduced our exposure to the volatile cellular end market that has been slowing growth and -- but has seen slowing growth and lower margins in recent years. In addition in 2020, we are in the process of shutting down two of our E-MS plants, which were subscale offering limited strategic value and lower margins. Looking forward, our balance sheet is in a strong position to pursue further acquisitions, as well as our organic investment needs. In the A&D market, our focus is to be an indispensable supplier to our customers, providing more capabilities and expanding our addressable market. In the commercial markets, our focus is to add more RF component capabilities around Anaren's core strengths, as well as to diversify our manufacturing footprint. We prefer that acquisitions across both the A&D and commercial markets for maximum benefit to the company. I would also like to update you on the COVID situation. We are currently managing through COVID-19 with relatively minor impact to our production. Those infected are returning to work after being cleared, following testing and quarantine protocols. We continue to use contact tracing and quarantine individuals who are in close contact with infected team members in addition to deep cleaning affected work areas. We also continue other measures such as extensive internal communications, masking, temperature checks and proper distancing in our facilities worldwide. Because of the stringent preventative measures in place and our culture of transparency in communications these events have had much less impact on our operations than we thought at the start of the year. Our leadership team continues to remain vigilant in mitigating the impact of COVID-19 as we enter the fall and winter in some parts of the world including the United States see an acceleration of cases. Now I'd like to review our end markets. All historical end market disclosures exclude the mobility business unit and the two E-MS plants we are shutting down. For more details on end market disclosures please refer to our third quarter earnings press release. The aerospace and defense end market represented 37% of total second quarter sales, compared to 36% of Q3 2019 sales and 33% of sales in Q2 2020. We expect sales in Q4 from this end market to represent about 38% of our total sales. We continue to see solid growth in our A&D segment with Q3 revenues up 7% year-on-year and an A&D program backlog of $625 million compared to $572 million in the year ago quarter. Weakness in the commercial aerospace end market was more than offset by strength in defense. Growth in the defense market is a result of our strong program alignment and key bookings for on in franchise programs such as AESA radar systems for the Aegis, Assure Japan program a variant of the U.S. LRDR program being built by Lockheed, as well as upgrading F-16 fighter jets with scalable agile beam radar built by Northrop. The medical industrial instrumentation end market contributed 19% of our total sales in the third quarter, compared to 18% in the year ago quarter and 21% in the second quarter of 2020. We were pleased to see this end market grow 9% year-on-year as we saw strength in our medical and instrumentation customers that was partially offset by weakness in our industrial customers. For the fourth quarter, we expect this market to be 16% of revenues as industrial customers continue to decline and we return to less elevated levels of demand for emergency medical products. Networking communications accounted for 16% of revenue during the third quarter of 2020. This compares to 16% in the third quarter of 2019 and 19% of revenue in the second quarter of 2020. We saw relative strength in the networking segment compared to the telecom segment as 5G builds took a pause. In Q4 we expect this segment to be 16% of revenue as 5G telecom demand remains subdued. Sales in the computing storage peripherals end market represented 13% of total sales in the third quarter compared to 12% in Q3 of 2019 and 13% in the second quarter of 2020. This end market grew 8% year-on-year from strength in our data center customers. We expect revenues in this end market to represent approximately 12% of fourth quarter sales. Automotive sales represented 13% of total sales during the third quarter of 2020, compared to 15% in the year ago quarter and 11% during the second quarter of 2020. While automotive sales declined year-over-year due to COVID-19 impacts we saw a 9% sequential growth, which was better than the slight decline originally expected. We expect automotive to contribute 16% of total sales in Q4 as the automotive recovery continues. Next I'll cover some details from the third quarter. Note that all of the following operations metrics exclude the mobility business unit and the two E-MS plants that are closing. During the quarter, our advanced technology business, which includes HDI, rigid flex, and RF subsystems and components accounted for approximately 29% of our revenue. This compares to approximately 25% in the year ago quarter and 28% in Q2. We are continuing to pursue new business opportunities and increase customer design engagement activities that will leverage our advanced technology capabilities in new markets. Capacity utilization in Asia Pacific was 63% in Q3, compared to 60% in the year ago quarter and 70% in Q2. Our overall capacity utilization in North America was 61% in Q3 compared to 58% in the year ago quarter and 63% in Q2. Our top five customers contributed 33% of total sales in the third quarter of 2020 compared to 27% in the second quarter of 2020. Our largest customer accounted for 13% of sales in the third quarter. At the end of Q3, our 90-day backlog which is subject to cancellations was $437.8 million compared to $378.8 million at the end of the third quarter last year and $436.6 million at the end of Q2. Our PCB book-to-bill ratio was 0.92 for the three months ended -- ending September 28. I'd like to conclude by again thanking our employees for continuing to contribute to TTM and our critical mission of inspiring innovation with our customers. Their efforts are particularly appreciated during these times by our customers in critical essential areas like defense and the medical industry. Despite COVID-19-related challenges we faced in the first nine months of this year, our business has performed better than expectations as a direct result of operational excellence end market diversification and our employees' concerted efforts to engage and support our customers. We've also taken positive strategic moves that will strengthen TTM for the long-term. Now, Todd will review our financial performance for the third quarter. Todd?